FDA Still Erasing Diversity Action Plans Despite RFK Jr.’s Promise To Finalize Guidance

FDA is continuing to erase draft guidance on diversity action plans it published last year before the Trump administration took office, despite a statement by HHS secretary nominee Robert F. Kennedy Jr. that he would finalize the guidance if confirmed and previous drug industry support for the program. FDA’s webpage for the draft guidance is now inaccessible, after a PDF of the guidance itself was previously removed . Federal agencies have pulled down many documents in response to President Donald...